Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma

Clinical trial NCT07007273 · RECRUITING

Trial details

NCT number: NCT07007273
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Sarcoma

Start date: 2025-06-20
Primary completion: 2030-07-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.